<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
July 14, 2000
-----------------------------------------
(Date of Report; Date of Earliest Event Reported)
Raytel Medical Corporation
--------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
----------------------------------
(State or other jurisdiction of incorporation)
<TABLE>
<S> <C>
0-27186 94-2787342
------------------------ --------------------------------
(Commission File Number) (IRS Employer Identification No.)
</TABLE>
<TABLE>
<S> <C>
2755 Campus Drive, Suite 200, San Mateo, CA 94403
----------------------------------------------------------
(address of principal executive offices) (Zip Code)
</TABLE>
(650) 349-0800
----------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE> 2
ITEM 5. OTHER EVENTS.
On July 17, 2000, Raytel Medical Corporation (the "Company") reported that
it entered into a transaction which effectively terminates the management
services agreement between the company and Southeast Texas Cardiology
Associates, or SETCA, a nine-physician cardiology practice located in Beaumont,
Texas. A copy of the press release announcing the terms of the transaction is
attached as Exhibit 99.1 and is incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial statements of business acquired:
Not applicable.
(b) Pro forma financial information:
Not applicable.
(c) Exhibits:
<TABLE>
<CAPTION>
Exhibit No. Description
----------- -----------
<S> <C>
99.1 Press Release dated July 17, 2000
</TABLE>
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
RAYTEL MEDICAL CORPORATION
Dated: July 25, 2000 By: /s/ RICHARD F. BADER
-----------------------------------
Richard F. Bader
Chairman and Chief Executive Officer
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit No. Description
----------- -----------
<S> <C>
99.1 Press Release dated July 17, 2000
</TABLE>
